Canopy Growth (CGC) Change in Intangibles (2020)
Canopy Growth (CGC) reported Change in Intangibles of $13.2 million for Q2 2020.
Canopy Growth (CGC) Change in Intangibles (2020) Analysis & Trends
Canopy Growth (CGC) has 1 years of Change in Intangibles data on file, last reported at $13.2 million in Q2 2020.
- For the quarter ending Q2 2020, Change in Intangibles changed N/A year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2021 stood at $13.2 million (changed N/A YoY), and the FY2021 full-year result was $14.5 million, changed N/A from the prior year.
- Change in Intangibles held at $13.2 million in Q2 2020.
- In the past five years, Change in Intangibles ranged from a high of $13.2 million in Q2 2020 to a low of $13.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | - |
| 10 | Canopy Growth | 279.47 Mn | 13.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 13.22 Mn |
| Jun 30, 2020 | 13.22 Mn |